Sequential treatment of Guillain-Barré syndrome with extracorporeal elimination and intravenous immunoglobulin

Journal of the Neurological Sciences

Volumn 137, Issue 2, 1996, Pages 145-149

  Haupt, Walter F ^a   Rosenow, Felix ^a   Van Der Ven, Christian ^a   Borberg, Helmut ^a   Pawlik, Gunter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Guillain Barr ; Immunomodulatory treatment; Intravenous immunoglobulin; Plasma exchange; Selective adsorption; Sequential treatment; Syndrome

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL;

ADULT; COMBINED MODALITY THERAPY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGED; PLASMA EXCHANGE; POLYRADICULONEUROPATHY; PROSPECTIVE STUDIES;

EID: 0029892966     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(95)00357-8     Document Type: Article

References (29)

1. Asbury, A.K. and D.R. Comblath (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol., 27 (Suppl.): 21-24.
2. Borberg, H., C. Jimenez, W.F. Haupt and F. Rosenow (1993) Current developments in the treatment of autoimmune diseases. In: Rewald, E. and Morell, A. (Eds.), Immunomodulation by Intravenous Immunoglobulin, Parthenon Press, Camforth, pp. 203-218.
3. Bussel, J.B., S. Saal and B. Gordon (1988) Combined plasma exchange and intravenous gammaglobulin in the treatment of patients with refractory immune thrombocytopenic purpura. Transfusion, 28: 38-41.
4. Castro, L.H.M. and A.H. Ropper (1993) Human immune globulin infusion in Guillain-Barré syndrome: worsening during and after treatment. Neurology, 43: 1034-1036.
5. Dutch Guillain-Barré Study Group (1994) Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. Ann. Neurol., 35: 749-752
6. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome (1987) Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann. Neurol., 22: 753-761.
7. Grob, D., D. Simpson, H. Mitsumoto, B. Hoch, F. Mokhatarian, A. Bender, M. Greenberg, A. Koo and S. Nakayama (1995) Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology, 45: 338-344.
8. Guillain-Barré Study Group (1985) Plasmapheresis and acute Guillain-Barré syndrome. Neurology, 35: 1096-1104.
9. Hartung, H.P., R.A. Hughes, W.A. Taylor, K. Heininger, K. Reiners and K.V. Toyka (1990) T-cell activation in Guillain-Barré syndrome and MS: elevated serum levels of soluble IL-2 receptors. Neurology, 40: 215-218.
10. Hartung, H.P., J.D. Pollard, G.K. Harvey and K.V. Toyka (1995a) Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part I. Muscle Nerve, 18: 137-153.
11. Hartung, H.P., J.D. Pollard, G.K. Harvey, K.V. Toyka (1995b) Immunopathogenesis and treatment of the Guillain-Barré syndrome. Part II. Muscle Nerve, 18: 154-164.
12. Haupt, W.F., F. Rosenow, H. Borberg, G. Pawlik and C. van der Ven (1994) Sequential treatment of acute Guillain-Barré syndrome with hemapheresis and i.v. IgG (abstract). Neurology, 44 (Suppl, 2): 129.
13. Haupt, W.F., H. Borberg and F. Rosenow (1995) Pilot study of a new treatment concept for acute Guillain-Barré Syndrome, Transf. Sci. 16: 139-144.
14. Hughes, R.A.C., J.M. Newsom-Davis, J.D. Perkin and J.M. Pierce (1978) Controlled trial of prednisolone in acute polyneuropathy. Lancet, 2: 750-753.
15. Imbach, P., V. d'Ampezzo, A. Hirt, E. Rossi, M. Vest, S. Barandun, C. Baumgartner, A. Morell, M. Schöni and H.P. Wagner (1981) High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet, 1228-1231.
16. Irani, D.N., D.R. Cornblath, V. Chaudhry, C. Borel and D.F. Hanley (1993) Relapse in Guillain-Barré syndrome after treatment with human immune globulin. Neurology, 43: 872-875.
17. Jiménez-Klingberg, C., F. Rosenow, P. Grieb, W.F. Haupt and H. Borberg (1991) Adsorption therapy with tryptophan conjugated polyvinyl alcohol gels in ten patients with acute Guillain-Barré syndrome. Infusionstherapie, 18 (Suppl): 44.
18. Kleyweg, R.P., F.G.A. Van der Meché and J. Meulstee (1988) Treatment of Guillain-Barré syndrome with high-dose gammaglobulin. Neurology, 38: 1639-1641.
19. Lisak, R.P. (1984) Plasma exchange in neurological diseases. Ann. Neurol., 41: 654-657.
20. Nydegger, U.E., R. Rieben and T.W. Jungi (1990) Synergy between plasma exchange and intravenous immunoglobulin. In: Nydegger, U.E. (Ed.), Therapeutic Hemapheresis in the 1990s. Curr. Stud. Hematol. Blood Transf. Karger, Basle, 57: 31-50.
21. Pencz, A. and A. Garnier (1990) Immunadsorption in der Behandlung der Polyradikulitis vom Typ Guillain-Barré. Nervenarzt, 61: 372-375.
22. Ronda, N., V. Hurez and M.D. Kazatchkine (1993) Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases. Vox sanguinis, 64: 65-72.
23. Ropper, A.H. (1992) The Guillain-Barré syndrome. New Engl. J. Med., 326: 1130-1136.
24. Rosenow, F., W.F. Haupt, P. Grieb, C. Jiménez-Klingberg and H. Borberg (1993) Plasma exchange and selective adsorption in Guillain-Barré syndrome. A comparison of therapies by clinical course and side effects. Transfus. Sci., 14: 13-15.
25. Schuchardt, V., M. Hotz, E. Hund, S. Sun, R. Heitmann and W. Hacke (1993) Erfahrungen mit hochdosiertem Immunglobulin G bei neuromuskulären Erkrankungen. Nervenarzt, 64: 98-103.
26. Shibuya, N., T. Sato, M. Osama, T. Takegami, S. Doi and S. Kawanami (1994) Immunoadsorption therapy for myasthenia gravis. J. Neurol. Neurosurg. Psychiatry, 57: 578-581.
27. Thornton, C.A. and R.C. Griggs (1994) Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann. Neurol., 35: 260-268.
28. Van der Meché, F.G.A., P.I.M. Schmitz and the Dutch Guillain-Barré Study Group (1992) A randomized trial comparing immune globulin and plasma exchange in Guillain-Barré syndrome. New Engl. J. Med., 326: 1123-1129.
29. Van der Meché, F.G.A. and P.A. van Doom (1995) Guillain-Barré syndrome and chronic demyelinating polyneuropathy: immune mechanisms and update on current therapies. Ann. Neurol., 37 (Suppl. 1) S14-S31.